Xtant Medical Holdings Stock Revenue
| XTNT Stock | USD 0.40 0.01 2.44% |
Xtant Medical Holdings fundamentals help investors to digest information that contributes to Xtant Medical's financial success or failures. It also enables traders to predict the movement of Xtant Stock. The fundamental analysis module provides a way to measure Xtant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xtant Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 91.3 M | 53.7 M |
Xtant | Revenue |
Xtant Medical Holdings Company Revenue Analysis
Xtant Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Xtant Medical Revenue | 91.3 M |
Most of Xtant Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xtant Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Xtant
Projected quarterly revenue analysis of Xtant Medical Holdings provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Xtant Medical match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Xtant Medical's stock price.
Xtant Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Xtant Medical is extremely important. It helps to project a fair market value of Xtant Stock properly, considering its historical fundamentals such as Revenue. Since Xtant Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xtant Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xtant Medical's interrelated accounts and indicators.
| 0.77 | 0.75 | 0.17 | 0.05 | -0.19 | ||
| 0.77 | 0.97 | 0.13 | -0.12 | -0.24 | ||
| 0.75 | 0.97 | -0.02 | -0.25 | -0.31 | ||
| 0.17 | 0.13 | -0.02 | 0.54 | 0.3 | ||
| 0.05 | -0.12 | -0.25 | 0.54 | -0.1 | ||
| -0.19 | -0.24 | -0.31 | 0.3 | -0.1 |
Click cells to compare fundamentals
Xtant Revenue Historical Pattern
Today, most investors in Xtant Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xtant Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Xtant Medical revenue as a starting point in their analysis.
Xtant Medical Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Xtant Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Xtant Medical Holdings reported 91.3 M of revenue. This is 98.8% lower than that of the Health Care Equipment & Supplies sector and 96.42% lower than that of the Health Care industry. The revenue for all United States stocks is 99.03% higher than that of the company.
Xtant Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.Xtant Medical is currently under evaluation in revenue category among its peers.
Xtant Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Xtant Medical from analyzing Xtant Medical's financial statements. These drivers represent accounts that assess Xtant Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Xtant Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 21.1M | 34.1M | 47.9M | 62.1M | 134.6M | 141.3M | |
| Enterprise Value | 94.4M | 50.3M | 46.5M | 58.9M | 152.4M | 107.5M |
Xtant Fundamentals
| Return On Equity | -0.0877 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.1) % | ||||
| Current Valuation | 84.96 M | ||||
| Shares Outstanding | 139.01 M | ||||
| Shares Owned By Insiders | 7.83 % | ||||
| Shares Owned By Institutions | 65.12 % | ||||
| Number Of Shares Shorted | 197.47 K | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 1.22 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 91.3 M | ||||
| Gross Profit | 32.14 M | ||||
| EBITDA | 5.07 M | ||||
| Net Income | 660 K | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 23.56 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | (9.52 M) | ||||
| Short Ratio | 6.92 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Price To Earnings To Growth | (0.03) X | ||||
| Target Price | 2.25 | ||||
| Number Of Employees | 207 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 55.6 M | ||||
| Total Asset | 92.61 M | ||||
| Retained Earnings | (243.01 M) | ||||
| Working Capital | 41.88 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
| Net Asset | 92.61 M |
About Xtant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.